Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 5 years by 12.8% on an annualized basis producing an average annual return of 24.48%. Currently, Halozyme Therapeutics has a market capitalization of $12.61 billion.
Buying $100 In HALO: If an investor had bought $100 of HALO stock 5 years ago, it would be worth $293.79 today based on a price of $110.28 for HALO at the time of writing.
Halozyme Therapeutics’s Performance Over Last 5 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Recent Comments